Similar articles

• Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.

  Bhattacharya D, Belperio PS, Shahoumian TA, Loomis TP, Goetz MB, Mole LA, Backus LI. Bhattacharya D, et al. Clin Infect Dis. 2017 Jun 15;64(12):1711-1720. doi: 10.1093/cid/cix111. Clin Infect Dis. 2017. PMID: 28199525
• Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.

  Gayam V, Hossain MR, Khalid M, Chakaraborty S, Mukhtar O, Dahal S, Mandal AK, Gill A, Garlapati P, Ramakrishnaiah S, Mowyad K, Sherigar J, Mansour M, Mohanty S. Gayam V, et al. Gut Liver. 2018 Nov 15;12(6):694-703. doi: 10.5009/gnl18004. Gut Liver. 2018. PMID: 29938459 Free PMC article.
• Treatment of chronic HCV genotype 1 coinfection.

  Boesecke C, Rockstroh JK. Boesecke C, et al. Curr HIV/AIDS Rep. 2015 Sep;12(3):326-35. doi: 10.1007/s11904-015-0278-4. Curr HIV/AIDS Rep. 2015. PMID: 26228050 Review.
• Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.

  Sikavi C, Chen PH, Lee AD, Saab EG, Choi G, Saab S. Sikavi C, et al. Hepatology. 2018 Mar;67(3):847-857. doi: 10.1002/hep.29642. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29108121 Review.
• Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea.

  Lim DH, Jeong JY, Nam S, Choi J, Kwon HC, Yoon YB, Kim Y, Chin B. Lim DH, et al. J Korean Med Sci. 2021 Nov 29;36(46):e308. doi: 10.3346/jkms.2021.36.e308. J Korean Med Sci. 2021. PMID: 34845874 Free PMC article.